Latest Regulatory News


ECHA: BPC Concludes on Union Authorisations

In late June 2019 the BP Committee (BPC) adopted four opinions, including one on the non-approval of the active substance (DBNPA – PT4) on ED properties and three (2 x PT4; 1 x PT18) on Union Authorisation (UA).

DBNPA is not approved for product type 4 unless one of the following BPR derogations can be applied:

  1. The risk of exposure to the environment, human and animal health is proven to be negligible; or
  2. There is evidence that the active substance is essential to prevent or control a serious danger to the environment, human or animal health; or
  3. The non-approval is shown to have a negative impact on society compared to the risks arising from the use of the substance.

The positive opinion supporting UA for PT18 is one application concerning a biocidal product family based on permethrin and S-Methoprene.

The next BPC meeting will be held in October 2019.

 

Latest Regulatory News

Oct-2022

News > Vet Medicine

The largest seasonal epidemic of Avian Influenza ever in Europe

Around 5,300 detections of highly pathogenic avian influenza (HPAI) virus were reported in poultry, captive and wild birds in 36 European/EEA countries and the UK...

Read More

Sep-2022

News

LKC 21st Birthday Event – September 2022

The earliest record dates back to 1363; no, not the origin of the European Regulatory Affairs company LKC – the Schloss Bottmingen, one of only...

Read More

Contact

LKC Switzerland Ltd
P.O. Box 167
4414 Füllinsdorf
Switzerland

Phone: +41 (0) 61 906 8500
LKC@lkc-ltd.com

Information

Registration Number: CHE-113.597.134

Upcoming Events

2007-2022 © Copyright LKC Switzerland Ltd

Sign Up for Newsletter

x